Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder

Pfizer

Status: Completed

Conditions: Over Active Bladder

Treatments: Drug: Fesoterodine

Study type: Observational

Funder types: Industry

Identifiers

NCT01260311

A0221085

Details and patient eligibility

About

This is an observational study and will determine the safety profile of fesoterodine in Filipino patients prescribed the drug. This is in compliance with the requirements of the Philippine Food and Drug Administration.

Full description

Sampling method is not applicable in this study. Only patients prescribed Fesoterodine will be enrolled.

Enrollment: 508 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Over-active bladder
• Prescribed with Fesoterodine

Exclusion criteria

• Hypersensitivity
• Urinary retention

Trial design

508 participants in 1 patient group

Patients prescribed with Fesoterodine

Description:

Patients diagnosed with Over-active bladder and prescribed with fesoterodine.

Treatment:

Drug: Fesoterodine